Lidocaine falls under the drug class of local anesthesia. Lidocaine patches are adhesive formulations that are used to help reduce itching and pain from certain skin conditions. Dermalid, Lidoderm, Ztildo are the prescription lidocaine transdermal patches used to relieve the pain of post-herpetic neuralgia. However, Absorbine Jr, Aspercreme, Lidocare, and Salonpas, among others are non-prescription lidocaine patches available to relieve minor pain in shoulders, arms, neck, and legs in adults and children 12 years of age and older.

Market Dynamics

Increase in application of lidocaine patch in pain management is expected to drive growth of the global lidocaine patch market over the forecast period. The lidocaine patch 5% exhibits efficacy to treat pain related to postherpetic neuralgia and is effective for pain related to osteoarthritis, creating an effective topical analgesic option for osteoarthritis. Moreover, increase in orevalence of lower back pain (LBP) is expected to boost growth of the market in the near future. For instance, according to an article published in Elsevier B.V. in January 2022, there were 568.4 million (95 ​% UI 505.0 to 640.6 million) prevalent cases of LBP (Low Back Pain) in 2019, with an age-standardized point prevalence estimate of 6,972.5 (95 ​% UI 6190.5 to 7860.5) per 100,000 population, globally.  Additionally, increasing incidence of herpes zoster and lack of preventive vaccination against shingles are expected to boost demand for lidocaine patches, which is further expected to fuel growth of the global lidocaine patches market during the forecast period. For instance, according to data published by the Centers for Disease Control and Prevention in October 2020, an estimated one million cases of herpes zoster occur annually in the U.S. The incidence for herpes zoster is around 4 cases per 1,000 U.S. population annually.

Key features of the study

• This report provides an in-depth analysis of the global lidocaine patches market, provides market size (USD Mn), and compound annual growth rate (CAGR %) for the forecast period (2026-2033), considering 2025 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new drug launches or approval, regional outlook, and competitive strategies adopted by the leading players
• It profiles leading players in the global lidocaine patches market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans.
• Key companies covered as a part of this study include Endo International plc, Teva Pharmaceutical Industries Ltd, Viatris Inc. (Mylan N.V.), Teikoku Pharma USA, Inc., Hisamitsu Pharmaceuticals Co. Inc., Galen Limited, Sorrento Therapeutics, Inc, Amneal Pharmaceuticals, Inc., Rhodes Pharmaceuticals L.P., 6iPain Healthcare Private Limited, and Sanofi S.A.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
• The global lidocaine patches market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global lidocaine patches market

Market Segmentation

• Strength Insights (Revenue, USD Mn, 2026 - 2033)
  • 5%
  • 4%
  • Others (10%, 20%, etc.)
• Adhesive Material Insights (Revenue, USD Mn, 2026 - 2033)
  • Aqueous
  • Non-aqueous
• Application Insights (Revenue, USD Mn, 2026 - 2033)
  • Post Herpetic Neuralgia (PHN)
  • Pain Indications
• Distribution Channel Insights (Revenue, USD Mn, 2026 - 2033)
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
• Regional Insights (Revenue, USD Mn, 2026 - 2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
• Key Players Insights
  • Endo International plc
  • Teva Pharmaceutical Industries Ltd
  • Viatris Inc. (Mylan N.V.)
  • Teikoku Pharma USA, Inc.
  • Hisamitsu Pharmaceuticals Co. Inc.
  • Galen Limited
  • Sorrento Therapeutics, Inc.
  • Amneal Pharmaceuticals, Inc.
  • Rhodes Pharmaceuticals L.P.
  • 6iPain Healthcare Private Limited
  • Sanofi S.A.